Table 6.
| ||||||
---|---|---|---|---|---|---|
Biochemical | IDH1 R132H | IDH1 R132C | ||||
| ||||||
Compd | R4 | R5 | IC50(μM) ± SDa | % inhibition ± SD at 38 μM | IC50(μM) ± SDa | % inhibition ± SD at 38 μM |
70 | Me | H | 1.5 ± 0.0 | 87 ± 3 | 64 ± 5 | |
71 | Me | Me | 1.2 ± 0.1 | 98 ± 3 | 2.0 ± 0.1 | 86 ± 1 |
72 | iPr | H | 2.8 ± 0.2 | 47 ± 1 | 54 ± 2 | |
73 | tBu | H | 65 ± 5 | 49 ± 4 | ||
74 | iBu | H | > 38 | 0.81 ± 0.05 | 56 ± 1 | |
75 | CH2CH2OH | H | 0.42 ± 0.00 | 104 ± 3 | 2.0 ± 0.1 | 96 ± 2 |
76 | CH2CH2OMe | H | 2.1 ± 0.0 | 92 ± 2 | 0.73 ± 0.10 | 102 ± 5 |
77 | CH2CO2H | H | 1.2 ± 0.0 | 106 ± 2 | 11 ± 1 | 87 ± 4 |
78 | CH2CH2NH2 | H | 0.38 ± 0.00 | 97 ± 1 | 2.0 ± 0.1 | 89 ± 1 |
79 | CH2CH2NHMe | H | 0.87 ± 0.06 | 101 ± 3 | 0.32 ± 0.02 | 96 ± 2 |
80 | CH2CONH2 | H | 1.6 ± 0.1 | 105 ± 3 | 3.8 ± 0.0 | 77 ± 14 |
81 | CH2CH2CH2NHMe | H | 1.0 ± 0.1 | 104 ± 3 | 0.91 ± 0.06 | 95 ± 0 |
82 | Ph | H | 40 ± 21 | 69 ± 11 | ||
83 | CH2Ph | H | > 38 | 41 ± 1 | ||
84 | cyclohexyl | H | > 38 | 31 ± 7 | ||
85 | N-piperidine | 51 ± 0 | 65 ± 3 | |||
86 | N-morpholine | 4.2 ± 0.0 | 82 ± 4 | 4.1 ± 0.3 | 71 ± 2 | |
87 | N-piperazine | 0.21 ± 0.00 | 103 ± 3 | 1.5 ± 0.0 | 93 ± 2 | |
88 | N-4-Me-piperazine | 2.9 ± 0.2 | 88 ± 1 | 1.2 ± 0.1 | 86 ± 3 |
IC50 values were determined utilizing the diaphorase and resazurin-coupled mIDH1 R132H and R132C assays. IC50 is reported for compounds with >75% inhibition at 38μM, the highest concentration tested.